Smith Group Asset Management, LLC
- SEC CIK
- 0001893134
- Latest filing
- Aug 3, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Smith Group Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −55,746−100.0% | Sold out | Holders |
| Q1 2026 | 55,746 | $24.9M | 1.3% | +3,695+7.1% | Added | Holders |
| Q4 2025 | 52,051 | $23.6M | 1.3% | +3,194+6.5% | Added | Holders |
| Q3 2025 | 48,857 | $19.1M | 1.1% | +2,602+5.6% | Added | Holders |
| Q2 2025 | 46,255 | $20.6M | 1.4% | +612+1.3% | Added | Holders |
| Q1 2025 | 45,643 | $22.1M | 1.7% | +2,010+4.6% | Added | Holders |
| Q4 2024 | 43,633 | $17.6M | 1.3% | −26−0.1% | Reduced | Holders |
| Q3 2024 | 43,659 | $20.3M | 1.7% | +749+1.7% | Added | Holders |
| Q2 2024 | 42,910 | $20.1M | 1.8% | +1,872+4.6% | Added | Holders |
| Q1 2024 | 41,038 | $17.2M | 1.0% | +4,454+12.2% | Added | Holders |
| Q4 2023 | 36,584 | $14.9M | 0.9% | – | No prior filing | Holders |
| Q2 2022 | – | – | – | – | Not filed | Holders |
| Q1 2022 | 19,060 | $4.97M | 0.3% | +19,060 | New | Holders |